Symbollon Pharmaceuticals Inc is categorized under Biological Products Manufacturers in Medway, MA and active since 1993.
Symbollon Pharmaceuticals Inc was established in 1993, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Biological Products Manufacturers business, which does work in the B2B market, and is classified as a Biological Products Manufacturers, under code number 325414 by the NAICS.
If you are seeking more information, feel free to contact Paul C Desjourdy at the company’s single location by writing to 51 Main St, Medway, Massachusetts MA 02053 or by phoning (814) 867-2777. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Symbollon Pharmaceuticals Inc |
| Contact Person: | Paul C Desjourdy |
| Address: | 51 Main St, Medway, Massachusetts 02053 |
| Phone Number: | (814) 867-2777 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 1993 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Biological Products Manufacturers |
| SIC Code: | 2836 |
| NAICS Code: | 325414 |
| Share This Business: |
Symbollon Pharmaceuticals Inc was started in 1993 to provide professional Biological Products Manufacturers under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Paul C Desjourdy for inquiries that concern Symbollon Pharmaceuticals Inc by calling the company number (814) 867-2777, as your correspondence is most welcome. Additionally, the physical location of the single location of Symbollon Pharmaceuticals Inc can be found at the coordinates 42.153876,-71.401315 as well as the street address 51 Main St in Medway, Massachusetts 02053.
For its online presence, you may visit Symbollon Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.